Clinical studies have shown it can help patients lose an average of 15-20% of their body weight
The effects were modest and the clinical relevance uncertain, but they highlight that GHS-R1a signaling extends beyond the somatotroph axis and has the potential to influence multiple endocrine systems
These include: Neurological symptoms : tingling or numbness in hands and feet (peripheral neuropathy), difficulty walking or balance problems, memory difficulties, or mood changes including depression Haematological signs : persistent fatigue, weakness, pale or jaundiced skin, or shortness of breath Glossitis : a sore, red, smooth tongue Cognitive symptoms : difficulty concentrating, confusion, or "brain fog" Seek urgent medical attention if you experience rapidly worsening neurological symptoms, significant difficulty walking, severe paraesthesia, or marked cognitive decline, as these may require immediate assessment
This pricing structure removes the cost barrier to finding your optimal therapeutic dose